Related Experiment Video
Updated: Oct 3, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Update on Management Recommendations for Advanced Cutaneous Squamous Cell Carcinoma
Jesús García-Foncillas1,2, Antonio Tejera-Vaquerizo3,4, Onofre Sanmartín5
1Departamento de Oncología, Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain.
Cutaneous squamous cell carcinoma (cSCC) is a common skin cancer. Early detection, individualized treatment, and novel therapies like cemiplimab improve outcomes, but long-term surveillance is crucial due to recurrence risk.
Area of Science:
- Dermatology
- Oncology
Background:
- Cutaneous squamous cell carcinoma (cSCC) incidence is rising globally.
- While rarely metastasizing, cSCC can cause local invasion and progression.
- Prognostic factors for cSCC require further clarification regarding their impact on survival.
Purpose of the Study:
- To review current understanding and management of cSCC.
- To highlight advances in diagnostic and therapeutic strategies.
- To emphasize the importance of individualized patient care and surveillance.
Main Methods:
- Review of recent literature on cSCC diagnosis and treatment.
- Analysis of prognostic factors and their clinical significance.
- Evaluation of novel systemic therapies, including immunotherapies.
Main Results:
- Non-invasive imaging and molecular testing improve diagnostic accuracy.
- Surgical excision remains the primary treatment; radiotherapy is used for specific cases.
- Cemiplimab (anti-PD-1) is a key therapy for advanced/metastatic cSCC.
- Individualized treatment decisions are essential due to uncertain prognostic factor associations.
Conclusions:
- Advances in diagnostics and systemic therapies are transforming cSCC management.
- Personalized treatment approaches are critical for optimal patient outcomes.
- Long-term surveillance is necessary due to the risk of recurrence and new primary tumors.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Peripheral Artery Disease IV: Nursing Management
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Clinical Applications of Epidermal Stem Cells

